Page 4 - Analytical Testing News Today

/PRNewswire/ -- The "Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration),...

China’s leading vaping media, Bluehole New Consumption, today publishes an industry comment on SMOORE‘s establishment of the world’s first E&L testing ...

The Valens Company Inc. (OTCMKTS:VLNCF – Get Rating)’s share price was down 6.3% during trading on Thursday . The company traded as low as $2.11 and last traded at $2.22. Approximately 216,036 shares traded hands during mid-day trading, a decline of 21% from the average daily volume of 274,854 shares. The stock had previously closed […]

Willow Biosciences Inc. (OTCMKTS:CANSF – Get Rating) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 210,800 shares, an increase of 29.6% from the February 13th total of 162,600 shares. Based on an average daily volume of 40,800 shares, the days-to-cover ratio is […]

Yorba Linda, CA (PRWEB) March 17, 2022 -- Yorba Linda, CA (March 17, 2022) Labroots, the leading scientific social networking website offering premier,

High Commission of Canada and Cereals Canada Unveil Bilingual Guide Book for Wheat Millers and Bakers

Raymond James lowered shares of Valens (OTCMKTS:VLNCF – Get Rating) from a market perform rating to an underperform rating in a report published on Thursday, The Fly reports. Valens stock traded down $0.12 during midday trading on Thursday, reaching $1.77. 85,297 shares of the stock traded hands, compared to its average volume of 274,854. The […]

UPPSALA, Sweden, January 25, 2022 / B3C newswire / -- Biotage is pleased to announce the launch of a sophisticated well plate evaporator, the TurboVap® 96 Dual – a second-generation system with two separate, and independently controlled evaporation compartments, building upon the reputable foundation of the Biotage...

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. As a global contract research organization (CRO), our broad technology offering is designed to address specific therapeutic development requirements, and provide the most highly customized solutions – ones that set our partners up for success at every stage.

A leader from the company discusses challenges in control labs and shares how a new solution aims to clear some key obstacles to greater effectiveness.